APA (7th ed.) Citation

Dyakov, I. N., & Kasyan, G. R. (2021). Pharmacoeconomic feasibility of using Mirabegron in patients with overactive bladder. Качественная клиническая практика, 1, 35. https://doi.org/10.37489/2588-0519-2021-1-35-45

Chicago Style (17th ed.) Citation

Dyakov, I. N., and G. R. Kasyan. "Pharmacoeconomic Feasibility of Using Mirabegron in Patients with Overactive Bladder." Качественная клиническая практика 1 (2021): 35. https://doi.org/10.37489/2588-0519-2021-1-35-45.

MLA (9th ed.) Citation

Dyakov, I. N., and G. R. Kasyan. "Pharmacoeconomic Feasibility of Using Mirabegron in Patients with Overactive Bladder." Качественная клиническая практика, 1, 2021, p. 35, https://doi.org/10.37489/2588-0519-2021-1-35-45.